The "Epigenetic Code Replication Machinery", ECREM: a promising drugable target of the epigenetic cell memory
- PMID: 17979715
- DOI: 10.2174/092986707782023244
The "Epigenetic Code Replication Machinery", ECREM: a promising drugable target of the epigenetic cell memory
Abstract
Discrete chemical modifications of the chromatin (DNA and primarily histones) can regulate gene expression or repression and can be transmitted to the descent (cells or organisms) thanks to an epigenetic memory. These modifications involve histone post-translational modifications, DNA methylation at CpG islands and small nuclear RNAs processes. They play fundamental roles in cell proliferation and differentiation. These two processes are crucial in particular during embryonic development, X chromosome inactivation in females, genomic imprinting, gene bookmarking, cell reprogramming, position effect and silencing of retroviral elements. While, only one major DNA modification is known, more than 150 post-translation modifications of histones have been reported, including methylations, acetylations, ubiquitinations, SUMOylations and phosphorylations. How these modifications are inherited from mother cells to daughter cells or from an organism to its descent remains a major scientific challenge. We propose here a macro-molecular complex, called ECREM for "Epigenetic Code REplication Machinery", as being involved in the inheritance of the epigenetic code. The composition of ECREM may vary in a spatio-temporal manner according to the chromatin state, the cell phenotype and the development stage. We describe the members of ECREM, responsible for the epigenetic code inheritance, i.e., enzymes involved in DNA methylation and histone post-translational modifications. Some of them, such as DNA methyltransferases (DNMTs), histone acetyltransferases (HATs) and histone deacetylases (HDACS including sirtuins), have been found to be deregulated in several types of pathologies and are already targeted by inhibitors. ECREM, thus, appears to be an interesting complex to be investigated in order to find new drugs for cancer, metabolic, neuro-degenerative and inflammatory diseases therapy.
Similar articles
-
Small molecule modulators in epigenetics: implications in gene expression and therapeutics.Subcell Biochem. 2007;41:397-428. Subcell Biochem. 2007. PMID: 17484138 Review.
-
Histone modification therapy of cancer.Adv Genet. 2010;70:341-86. doi: 10.1016/B978-0-12-380866-0.60013-7. Adv Genet. 2010. PMID: 20920755 Review.
-
Screening for compounds that modulate epigenetic regulation of the transcriptome: an overview.J Biomol Screen. 2011 Dec;16(10):1137-52. doi: 10.1177/1087057111417871. Epub 2011 Oct 14. J Biomol Screen. 2011. PMID: 22002420 Review.
-
Histone modification enzymes: novel targets for cancer drugs.Expert Opin Emerg Drugs. 2004 May;9(1):135-54. doi: 10.1517/eoed.9.1.135.32947. Expert Opin Emerg Drugs. 2004. PMID: 15155140 Review.
-
Gene expression profiling of epigenetic chromatin modification enzymes and histone marks by cigarette smoke: implications for COPD and lung cancer.Am J Physiol Lung Cell Mol Physiol. 2016 Dec 1;311(6):L1245-L1258. doi: 10.1152/ajplung.00253.2016. Epub 2016 Oct 28. Am J Physiol Lung Cell Mol Physiol. 2016. PMID: 27793800 Free PMC article.
Cited by
-
Epigenetic perturbations in the pathogenesis of mustard toxicity; hypothesis and preliminary results.Interdiscip Toxicol. 2008 Dec;1(3-4):236-41. doi: 10.2478/v10102-010-0048-5. Interdiscip Toxicol. 2008. PMID: 21218122 Free PMC article.
-
Epigenetics in heart failure phenotypes.BBA Clin. 2016 May 30;6:31-7. doi: 10.1016/j.bbacli.2016.05.005. eCollection 2016 Dec. BBA Clin. 2016. PMID: 27335803 Free PMC article. Review.
-
The phosphorylation to acetylation/methylation cascade in transcriptional regulation: how kinases regulate transcriptional activities of DNA/histone-modifying enzymes.Cell Biosci. 2022 Jun 3;12(1):83. doi: 10.1186/s13578-022-00821-7. Cell Biosci. 2022. PMID: 35659740 Free PMC article. Review.
-
The evolution of epitype.Plant Cell. 2010 Jun;22(6):1658-66. doi: 10.1105/tpc.110.075481. Epub 2010 Jun 15. Plant Cell. 2010. PMID: 20551346 Free PMC article.
-
Targeting microRNA/UHRF1 pathways as a novel strategy for cancer therapy.Oncol Lett. 2018 Jan;15(1):3-10. doi: 10.3892/ol.2017.7290. Epub 2017 Oct 30. Oncol Lett. 2018. PMID: 29285183 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources